This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is a common problem among patients with central sleep apnea? a. Obesity c. ... (Read 76 times)

stephzh

  • Hero Member
  • *****
  • Posts: 556
Which of the following is a common problem among patients with central sleep apnea?
 
  a. Obesity c. Depression
  b. Insomnia d. Hypersomnolence

Question 2

Which criteria related to measurements of PETCO2 are used to determine sleep-disordered breath-ing in children?
 
  a. PETCO2 values of >8 mm Hg above base-line
  b. PETCO2 values of >12 mm Hg above base-line
  c. PETCO2 values of >40 mm Hg for at least 25 of total sleep time
  d. PETCO2 values of >45 mm Hg for at least 60 of total sleep time



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

stanleka1

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

ANS: C
Depression is a common finding in patients with central sleep apnea. Patients with central sleep apnea do not normally report insomnia and hypersomnolence and typically have a normal body habitus.

Answer to Question 2

ANS: D
For children, it has been suggested that PETCO2 values of greater than 45 mm Hg for at least 60 of the total sleep time or PETCO2 values greater than 13 mm Hg above baseline values indicate sleep-disordered breathing.





 

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

For a complete list of videos, visit our video library